Zuellig Pharma Specialty Solutions (India) Private Limited - Company Profile

It is a transport and logistics foreign private limited company based in Bhiwandi, Maharashtra, India, established in 2015.

2015 Bhiwandi, Maharashtra, India Active

Last Updated: February 23, 2026

Access Report

About Zuellig Pharma Specialty Solutions (India) Private Limited

Zuellig Pharma Specialty Solutions (India) Private Limited, a active foreign private limited company, was established on 02 March 2015 in Bhiwandi, Maharashtra, India. Engaging in integrated & diversified logistics services within the transport and storage sector, it holds CIN: U74120MH2015FTC262353. Registered under ROC Roc Mumbai Ii. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹3.94 M.

It upholds a compliant status. Its leadership includes Evasio Barbero (Director), Giuseppe Leo (Director), Dharmesh Jayendrakumar Parikh (Director). Past directors included Evasio Barbero, Jayanti Palassena Vaidyanath, Georg Felix Schulz. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Gala No-16, 17A & 17B, Building No-B1, City Link Warehousing Complex,, Mumbai Nasik Highway, Village- Vadape, Bhiwandi, Thane, Bhiwandi, Maharashtra, 421302.

Company Details

CIN/LLPIN
U74120MH2015FTC262353
Registration Number
262353
Incorporation Date
02 March 2015
Authorized Capital
₹1.00 Cr
Paid-Up Capital
₹3.94 M
ROC Code
Roc Mumbai Ii
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.00 Cr as on 23-02-2026
Paid Up Capital ₹ 3.94 M as on 23-02-2026
Company Age 11 Year, 2 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** -31.96% (FY 2022)
Profit Growth **** -25.45% (FY 2022)
Ebitda **** -39.61% (FY 2022)
Net Worth 10.33% (FY 2022)
Total Assets -9.83% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Zuellig Pharma Specialty Solutions (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Zuellig Pharma Specialty Solutions (India) Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Evasio Barbero	Director	14 Jan 2022	Current
Giuseppe Leo	Director	03 Mar 2015	Current
Dharmesh Jayendrakumar Parikh	Director	16 Jul 2021	Current
Chee Peng Lim	Director	21 Feb 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	05 Dec 2022	Past
Pramod Abcsdd	Director	01 Dec 2020	Past
Pramod Abcsdd	Director	22 Sep 2020	Past
Pramod Abcsdd	Additional Director	30 Sep 2016	Past
Pramod Abcsdd	Additional Director	30 Dec 2021	Past
Pramod Abcsdd	Director	01 Dec 2021	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zuellig Pharma Specialty Solutions (India).

Zuellig Pharma Specialty Solutions (India) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 31.96% decrease. The company also saw a substantial fall in profitability, with a 25.45% decrease in profit. The company's net worth Soared by an impressive increase of 10.33%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-31.96%

*******

Revenue from Operations

*******

-34.23%

*******

Total Assets

*******

-9.83%

*******

Profit or Loss

*******

-25.45%

*******

Net Worth

*******

10.33%

*******

EBITDA

*******

-39.61%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zuellig Pharma Specialty Solutions (India)?

In 2022, Zuellig Pharma Specialty Solutions (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Zuellig Pharma Specialty Solutions (India)?

Unlock and access historical data on people associated with Zuellig Pharma Specialty Solutions (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Zuellig Pharma Specialty Solutions (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zuellig Pharma Specialty Solutions (India)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zuellig Pharma Specialty Solutions (India)

Recent Activity within the Organization

Annual General Meeting

The activity Zuellig Pharma Specialty Solutions (India) Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
29 Sep 2025
Balance Sheet

Zuellig Pharma Specialty Solutions (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii. was recorded as a recent event.
31 Mar 2025
Director Appointment

Chee Peng Lim was appointed as a Director was appointed as a Director on 21 Feb 2023 & has been associated with this company since 3 years 2 months . was recorded as a recent event.
21 Feb 2023
Director Appointment

Progress on Evasio Barbero was appointed as a Director was appointed as a Director on 14 Jan 2022 & has been associated with this company since 4 years 4 months . was documented.
14 Jan 2022
Director Appointment

Dharmesh Jayendrakumar Parikh was appointed as a Director was appointed as a Director on 16 Jul 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.
16 Jul 2021
Director Appointment

The activity Giuseppe Leo was appointed as a Director was appointed as a Director on 03 Mar 2015 & has been associated with this company since 11 years 2 months . was completed.
03 Mar 2015

Explore recent activity and updates - View Recent Activity